Elen Almeida Romão
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elen Almeida Romão has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Miguel Moyses Neto
Universidade de São Paulo, Brazil
3 shared publications - Valdes Roberto Bollela
Universidade de São Paulo, Brazil
3 shared publications - Carlos Augusto Fernandes Molina
Departamento de Cirurgia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil
2 shared publications - Dmitry José de Santana Sarmento
Department of Dentistry, Paraíba State University, Araruna, Paraíba, Brazil
2 shared publications - Julio Cesar Moriguti
Universidade de São Paulo
2 shared publications - Lucila Leico Kagohara Elias
Department of Physiology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 70 (2) , 1-8
Intact and bioactive PTH values are strongly correlated in kidney transplant recipients
Objective: This study aims to evaluate the correlation between parathyroid hormone measured by a second-generation assay (PTHG2) and by a third-generation assay (PTHG3), and their association with mineral and bone disorder (MBD) biochemical parameters and radiographic vascular calcification score in kidney transplant recipients (KTRs). Materials and methods: We evaluated 87 KTRs and measured PTHG2, PTHG3, biochemical profile, urinary fractional excretion of calcium (FE Ca) and phosphate, 25(OH)D3, and Kauppila score for vascular calcification. Statistical analysis: Non-parametric tests and logistic [...] Abstract Objective: This study aims to evaluate the correlation between parathyroid hormone measured by a second-generation assay (PTHG2) and by a third-generation assay (PTHG3), and their association with mineral and bone disorder (MBD) biochemical parameters and radiographic vascular calcification score in kidney transplant recipients (KTRs). Materials and methods: We evaluated 87 KTRs and measured PTHG2, PTHG3, biochemical profile, urinary fractional excretion of calcium (FE Ca) and phosphate, 25(OH)D3, and Kauppila score for vascular calcification. Statistical analysis: Non-parametric tests and logistic
- 1 January 2026
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 70 (2) , 1-8
Open AccessIntact and bioactive PTH values are strongly correlated in kidney transplant recipients
Objective: This study aims to evaluate the correlation between parathyroid hormone measured by a second-generation assay (PTHG2) and by a third-generation assay (PTHG3), and their association with mineral and bone disorder (MBD) biochemical parameters and radiographic vascular calcification score in kidney transplant recipients (KTRs). Materials and methods: We evaluated 87 KTRs and measured PTHG2, PTHG3, biochemical profile, urinary fractional excretion of calcium (FE Ca) and phosphate, 25(OH)D3, and Kauppila score for vascular calcification. Statistical analysis: Non-parametric tests and logistic [...] Abstract Objective: This study aims to evaluate the correlation between parathyroid hormone measured by a second-generation assay (PTHG2) and by a third-generation assay (PTHG3), and their association with mineral and bone disorder (MBD) biochemical parameters and radiographic vascular calcification score in kidney transplant recipients (KTRs). Materials and methods: We evaluated 87 KTRs and measured PTHG2, PTHG3, biochemical profile, urinary fractional excretion of calcium (FE Ca) and phosphate, 25(OH)D3, and Kauppila score for vascular calcification. Statistical analysis: Non-parametric tests and logistic
- Open Access
- 3 September 2024
- Published by Spandidos Publications in Oncology Letters
- Vol. 28 (5) , 1-5
Effective treatment of collecting duct carcinoma in a recipient of a kidney transplant: A case report
Collecting duct carcinoma (CDC) is a rare disease associated with a high mortality rate. The present study describes the case of a recipient of a kidney transplant with metastatic allograft CDC whose treatment was successful. The patient underwent nephrectomy, and chemotherapy with gemcitabine and cisplatin, while undergoing haemodialysis treatment and remained in remission after 6 years of follow‑up. There is a lack of information about the treatment and clinical management of CDC; however, the combination of gemcitabine and cisplatin remains as first‑line therapy. The challenge of this case was integrating chemotherapy sessions with dialysis therapy to maintain the effectiveness, tolerability and safety of the oncological treatment. In the present case report, the success of chemotherapy with gemcitabine and cisplatin was demonstrated in a metastatic renal allograft CDC in a patient with end‑stage renal disease, with few side effects and no recurrence of the disease 6 years after the end of treatment.
- 3 September 2024
- Published by Spandidos Publications in Oncology Letters
- Vol. 28 (5) , 1-5
Open AccessEffective treatment of collecting duct carcinoma in a recipient of a kidney transplant: A case report
Collecting duct carcinoma (CDC) is a rare disease associated with a high mortality rate. The present study describes the case of a recipient of a kidney transplant with metastatic allograft CDC whose treatment was successful. The patient underwent nephrectomy, and chemotherapy with gemcitabine and cisplatin, while undergoing haemodialysis treatment and remained in remission after 6 years of follow‑up. There is a lack of information about the treatment and clinical management of CDC; however, the combination of gemcitabine and cisplatin remains as first‑line therapy. The challenge of this case was integrating chemotherapy sessions with dialysis therapy to maintain the effectiveness, tolerability and safety of the oncological treatment. In the present case report, the success of chemotherapy with gemcitabine and cisplatin was demonstrated in a metastatic renal allograft CDC in a patient with end‑stage renal disease, with few side effects and no recurrence of the disease 6 years after the end of treatment.
- Open Access
- 25 January 2023
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 26 (1)
Lesões Orais Malignas Tardias após Transplante Renal
Objetivo: Revisar casos de malignidades da cavidade oral disponíveis na literatura em receptores de transplantes renais. Métodos: Foi realizada uma pesquisa no banco de dados PubMed usando os termos “oral cancer”, “mouth neoplasms”, “renal transplantation” e “kidney transplantation”. Independentemente da data de publicação, as publicações foram escolhidas por dois pesquisadores após considerarem cuidadosamente os títulos e resumos e lerem cada artigo em sua totalidade. Resultados: Foram encontrados 12 artigos com casos de malignidades orais em receptores de transplantes renais. No total, 31 neoplasias malignas foram diagnosticadas na cavidade oral, das quais 64,5% (20/31) eram carcinomas espinocelulares; o sarcoma de Kaposi representou 12,9% (4/31) dos casos. Lábios e língua foram os locais mais afetados mencionados mais frequentemente nos artigos avaliados. O tempo pós-transplante variou de 8 meses a 23 anos, e vários imunossupressores foram utilizados. Conclusões: Os receptores de transplante renal devem ser encaminhados regularmente a dentistas e outros profissionais médicos que trabalham no diagnóstico de lesões malignas da cavidadeoral a serem avaliadas, e novos casos de câncer oral poderão ser reconhecidos precocemente para tratamento. Esta estratégia poderá melhorar a sobrevivência dos pacientes com esta doença ameaçadora.
- 25 January 2023
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 26 (1)
Open AccessLesões Orais Malignas Tardias após Transplante Renal
Objetivo: Revisar casos de malignidades da cavidade oral disponíveis na literatura em receptores de transplantes renais. Métodos: Foi realizada uma pesquisa no banco de dados PubMed usando os termos “oral cancer”, “mouth neoplasms”, “renal transplantation” e “kidney transplantation”. Independentemente da data de publicação, as publicações foram escolhidas por dois pesquisadores após considerarem cuidadosamente os títulos e resumos e lerem cada artigo em sua totalidade. Resultados: Foram encontrados 12 artigos com casos de malignidades orais em receptores de transplantes renais. No total, 31 neoplasias malignas foram diagnosticadas na cavidade oral, das quais 64,5% (20/31) eram carcinomas espinocelulares; o sarcoma de Kaposi representou 12,9% (4/31) dos casos. Lábios e língua foram os locais mais afetados mencionados mais frequentemente nos artigos avaliados. O tempo pós-transplante variou de 8 meses a 23 anos, e vários imunossupressores foram utilizados. Conclusões: Os receptores de transplante renal devem ser encaminhados regularmente a dentistas e outros profissionais médicos que trabalham no diagnóstico de lesões malignas da cavidadeoral a serem avaliadas, e novos casos de câncer oral poderão ser reconhecidos precocemente para tratamento. Esta estratégia poderá melhorar a sobrevivência dos pacientes com esta doença ameaçadora.
- Open Access
- 25 January 2023
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 26 (1)
Late malignant oral lesions after kidney transplantation
Objective: To review cases of oral cavity malignancies available in the literature in kidney transplant recipients. Methods:A search was carried out in the PubMed database using the terms “oral cancer,” “mouth neoplasms,” “renal transplantation,” and “kidney transplantation.” Regardless of the publication date, the publications were chosen by two researchers after they carefully considered the titles and abstracts and read each article in its entirety. Results: Twelve articles were found with cases of oral malignancies in kidney transplant recipients. In all, 31 malignant neoplasms were diagnosed in the oral cavity, of which 64.5% (20/31) were squamous cell carcinomas; Kaposi’s sarcoma represented 12.9% (4/31) of the cases. Lips and tongue were the most affected sites mentioned most frequently in the articles evaluated. Post-transplantation time ranged from 8 months to 23 years, and several immunosuppressants were used. Conclusions: Kidney transplant recipients should be regularly forwarded to dentists and other medical professionals who work in diagnosing malignant lesions of the oral cavity to be evaluated, and new cases of oral cancer can be recognized early to treatment. This strategy could improve the survival of patients with this threatening disease.
- 25 January 2023
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 26 (1)
Open AccessLate malignant oral lesions after kidney transplantation
Objective: To review cases of oral cavity malignancies available in the literature in kidney transplant recipients. Methods:A search was carried out in the PubMed database using the terms “oral cancer,” “mouth neoplasms,” “renal transplantation,” and “kidney transplantation.” Regardless of the publication date, the publications were chosen by two researchers after they carefully considered the titles and abstracts and read each article in its entirety. Results: Twelve articles were found with cases of oral malignancies in kidney transplant recipients. In all, 31 malignant neoplasms were diagnosed in the oral cavity, of which 64.5% (20/31) were squamous cell carcinomas; Kaposi’s sarcoma represented 12.9% (4/31) of the cases. Lips and tongue were the most affected sites mentioned most frequently in the articles evaluated. Post-transplantation time ranged from 8 months to 23 years, and several immunosuppressants were used. Conclusions: Kidney transplant recipients should be regularly forwarded to dentists and other medical professionals who work in diagnosing malignant lesions of the oral cavity to be evaluated, and new cases of oral cancer can be recognized early to treatment. This strategy could improve the survival of patients with this threatening disease.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Educação Médica
- Vol. 47 (2) , e076
Reflexões sobre a utilização do Teste de Progresso na avaliação programática do estudante
Resumo: Introdução: O Teste de Progresso (TP) constitui modalidade estabelecida e bem-sucedida de avaliação de conhecimentos do estudante das profissões da saúde, principalmente os de Medicina, com potencial de contribuir substancialmente para as finalidades formativa e informativa (controle de qualidade e indicação de melhoria nos processos de ensino e aprendizagem). Adicionalmente, o TP apresenta características adequadas à sua inclusão em sistemas institucionais de avaliação que privilegiem a finalidade formativa, como a avaliação programática (AP), mas que cumprem também a somativa. Nas escolas que vêm definindo ações visando à introdução da AP em seus cursos de graduação, é necessária a reflexão sobre as fortalezas e limitações da utilização do TP no sistema de avaliação. Desenvolvimento: A partir das considerações de um grupo de trabalho representativo de toda a instituição, incumbido de propor meios de introdução da AP em um novo currículo para o curso de Medicina, contando com assessoria internacional com experiência tanto no TP como na AP, elaborou-se reflexão sobre esse tema, baseada na experiência dos autores e em dados da literatura. Propõe-se que, dentro da perspectiva longitudinal da AP, o TP constitua um dos pilares na avaliação de conhecimentos. O TP pode servir de base para acompanhamento do estudante, no contexto da sua turma (coorte), e seus resultados devem ser discutidos com o mentor que o acompanha e lhe dá suporte. O TP deve ter também papel central na gestão, como fonte de informações para eventual revisão e qualificação do currículo e das suas atividades de ensino e aprendizagem. É previsível que a utilização do TP na AP traga diferentes desafios e barreiras, que serão mais facilmente superados se houver na instituição experiências já consolidadas de aplicação de exames institucionais e de desenvolvimento docente para a elaboração de questões objetivas de boa qualidade. Conclusão: A efetividade do TP dentro do sistema institucional de AP vai depender de medidas que visem aumentar a sua efetividade na avaliação e que estimulem a participação ativa do estudante, refletindo sobre seu desempenho no TP, com o apoio do seu mentor, de modo a se engajar em ações que fomentem a autorregulação da aprendizagem.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Educação Médica
- Vol. 47 (2) , e076
Open AccessReflexões sobre a utilização do Teste de Progresso na avaliação programática do estudante
Resumo: Introdução: O Teste de Progresso (TP) constitui modalidade estabelecida e bem-sucedida de avaliação de conhecimentos do estudante das profissões da saúde, principalmente os de Medicina, com potencial de contribuir substancialmente para as finalidades formativa e informativa (controle de qualidade e indicação de melhoria nos processos de ensino e aprendizagem). Adicionalmente, o TP apresenta características adequadas à sua inclusão em sistemas institucionais de avaliação que privilegiem a finalidade formativa, como a avaliação programática (AP), mas que cumprem também a somativa. Nas escolas que vêm definindo ações visando à introdução da AP em seus cursos de graduação, é necessária a reflexão sobre as fortalezas e limitações da utilização do TP no sistema de avaliação. Desenvolvimento: A partir das considerações de um grupo de trabalho representativo de toda a instituição, incumbido de propor meios de introdução da AP em um novo currículo para o curso de Medicina, contando com assessoria internacional com experiência tanto no TP como na AP, elaborou-se reflexão sobre esse tema, baseada na experiência dos autores e em dados da literatura. Propõe-se que, dentro da perspectiva longitudinal da AP, o TP constitua um dos pilares na avaliação de conhecimentos. O TP pode servir de base para acompanhamento do estudante, no contexto da sua turma (coorte), e seus resultados devem ser discutidos com o mentor que o acompanha e lhe dá suporte. O TP deve ter também papel central na gestão, como fonte de informações para eventual revisão e qualificação do currículo e das suas atividades de ensino e aprendizagem. É previsível que a utilização do TP na AP traga diferentes desafios e barreiras, que serão mais facilmente superados se houver na instituição experiências já consolidadas de aplicação de exames institucionais e de desenvolvimento docente para a elaboração de questões objetivas de boa qualidade. Conclusão: A efetividade do TP dentro do sistema institucional de AP vai depender de medidas que visem aumentar a sua efetividade na avaliação e que estimulem a participação ativa do estudante, refletindo sobre seu desempenho no TP, com o apoio do seu mentor, de modo a se engajar em ações que fomentem a autorregulação da aprendizagem.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Educação Médica
- Vol. 47 (2) , e076
Reflections on the use of the Progress Test in the programmatic student assessment
Introduction: The Progress Test (PT) is a well-established and mostly successful modality of student knowledge assessment in the health professions, mainly those in the medical area, with the potential to contribute substantially to the formative and informative purposes (quality control and indication of improvement in the teaching-learning processes). Additionally, the PT has characteristics that are adequate for its inclusion in institutional evaluation systems that facilitate the formative purpose, such as programmatic assessment (PA), but that also meet the summative purpose. In schools that have defined actions aimed at introducing PA in their undergraduate courses, it is necessary to reflect on the strengths and limitations of using PT in the evaluation system. Development: based on the considerations of a working group representative of the entire institution, tasked with proposing means of introducing PA in a new curriculum for the medical course, with international advice with experience in both PT and PA, we generated a reflection on this topic, based on the authors’ experience and data from the literature. It is proposed that, within the longitudinal perspective of the PA, the PT constitutes one of the pillars in the assessment of knowledge. The PT can be used as a basis for monitoring the students, in the context of their class (cohort), and its results should be discussed with the mentors who accompanies and supports them. The PT must also play a central role in management, as a source of information for eventual review and qualification of the curriculum and its teaching-learning activities. It is predictable that the use of the PT in PA will bring different challenges and barriers, which will be more easily overcome if the institution has already consolidated experiences in the application of institutional exams and in faculty development for the production of good quality objective questions. Conclusion: the effectiveness of the PT within the institutional PA system will depend on measures aimed at increasing its effectiveness in the assessment and that encourage the student’s active participation, reflecting on their performance in the PT, with the support of their mentor, aiming to engage in actions that encourage learning self-regulation.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Educação Médica
- Vol. 47 (2) , e076
Open AccessReflections on the use of the Progress Test in the programmatic student assessment
Introduction: The Progress Test (PT) is a well-established and mostly successful modality of student knowledge assessment in the health professions, mainly those in the medical area, with the potential to contribute substantially to the formative and informative purposes (quality control and indication of improvement in the teaching-learning processes). Additionally, the PT has characteristics that are adequate for its inclusion in institutional evaluation systems that facilitate the formative purpose, such as programmatic assessment (PA), but that also meet the summative purpose. In schools that have defined actions aimed at introducing PA in their undergraduate courses, it is necessary to reflect on the strengths and limitations of using PT in the evaluation system. Development: based on the considerations of a working group representative of the entire institution, tasked with proposing means of introducing PA in a new curriculum for the medical course, with international advice with experience in both PT and PA, we generated a reflection on this topic, based on the authors’ experience and data from the literature. It is proposed that, within the longitudinal perspective of the PA, the PT constitutes one of the pillars in the assessment of knowledge. The PT can be used as a basis for monitoring the students, in the context of their class (cohort), and its results should be discussed with the mentors who accompanies and supports them. The PT must also play a central role in management, as a source of information for eventual review and qualification of the curriculum and its teaching-learning activities. It is predictable that the use of the PT in PA will bring different challenges and barriers, which will be more easily overcome if the institution has already consolidated experiences in the application of institutional exams and in faculty development for the production of good quality objective questions. Conclusion: the effectiveness of the PT within the institutional PA system will depend on measures aimed at increasing its effectiveness in the assessment and that encourage the student’s active participation, reflecting on their performance in the PT, with the support of their mentor, aiming to engage in actions that encourage learning self-regulation.
- Open Access
- 13 September 2022
- Published by Wolters Kluwer Health in Transplantation
- Vol. 106 (9S) , S400
412.1: Lip Actinic Cheilitis and Its Relationship to Clinical Characteristics and Immunosuppression in Kidney Transplant Recipients
- 13 September 2022
- Published by Wolters Kluwer Health in Transplantation
- Vol. 106 (9S) , S400
Open Access412.1: Lip Actinic Cheilitis and Its Relationship to Clinical Characteristics and Immunosuppression in Kidney Transplant Recipients
- Open Access
- 20 August 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (2) , 610-625
Development and validation of a simple web-based tool for early prediction of COVID-19-associated death in kidney transplant recipients
- 20 August 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (2) , 610-625
Open AccessDevelopment and validation of a simple web-based tool for early prediction of COVID-19-associated death in kidney transplant recipients
- Open Access
- 17 March 2021
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 22, e8
Management of chronic kidney disease: perspectives of Brazilian primary care physicians
Aim: To investigate primary care physicians’ knowledge of and attitudes toward care for chronic kidney disease patients. Background: In Brazil, care for chronic kidney disease, a global public health problem, is provided by the Brazilian National Health System, which is organized around primary care. The study aimed to investigate the knowledge and attitudes of primary care physicians about the management of chronic kidney disease. Method: This research is based on quantitative and qualitative data. The participants were 92 physicians from 81 primary care units located in eight cities of the São Paulo/Brazil health region, who answered a self-administered questionnaire. Findings: Only 59% and 58% of the physicians recognized smoking and obesity, respectively, as risk factors for chronic kidney disease. Health appointments and drug therapy predominated as disease prevention strategies and less than 30% mentioned multiprofessional care and health education groups. For early diagnosis, isolated serum creatinine was the most used test and 64.6% stated they classified the disease stages. Exclusive follow-up in primary care decreased from 79% in stage 1 to 19.5% in stage 3B and the patients’ monitoring in the healthcare network varied from 8.7% in stage 1 to 70.6% in stages 4 and 5ND, suggesting early referrals and lack of referral at the necessary stages. Access to information on the referred patient was, predominantly, through the patient’s report and 74% of the physicians did not have matrix support regarding chronic kidney disease. Conclusion: The study showed that the healthcare teams need to update their knowledge and procedures to be able to provide a comprehensive and efficient approach to treating chronic kidney disease in primary care.
- 17 March 2021
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 22, e8
Open AccessManagement of chronic kidney disease: perspectives of Brazilian primary care physicians
Aim: To investigate primary care physicians’ knowledge of and attitudes toward care for chronic kidney disease patients. Background: In Brazil, care for chronic kidney disease, a global public health problem, is provided by the Brazilian National Health System, which is organized around primary care. The study aimed to investigate the knowledge and attitudes of primary care physicians about the management of chronic kidney disease. Method: This research is based on quantitative and qualitative data. The participants were 92 physicians from 81 primary care units located in eight cities of the São Paulo/Brazil health region, who answered a self-administered questionnaire. Findings: Only 59% and 58% of the physicians recognized smoking and obesity, respectively, as risk factors for chronic kidney disease. Health appointments and drug therapy predominated as disease prevention strategies and less than 30% mentioned multiprofessional care and health education groups. For early diagnosis, isolated serum creatinine was the most used test and 64.6% stated they classified the disease stages. Exclusive follow-up in primary care decreased from 79% in stage 1 to 19.5% in stage 3B and the patients’ monitoring in the healthcare network varied from 8.7% in stage 1 to 70.6% in stages 4 and 5ND, suggesting early referrals and lack of referral at the necessary stages. Access to information on the referred patient was, predominantly, through the patient’s report and 74% of the physicians did not have matrix support regarding chronic kidney disease. Conclusion: The study showed that the healthcare teams need to update their knowledge and procedures to be able to provide a comprehensive and efficient approach to treating chronic kidney disease in primary care.
- Open Access
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Revista Latino-Americana de Enfermagem
- Vol. 29, e3442
Prevalence of latent tuberculosis and associated factors in patients with chronic kidney disease on hemodialysis
Objective: to identify the prevalence of latent tuberculosis in patients with chronic kidney disease on hemodialysis and associated factors. Method: a cross-sectional study conducted with 176 patients with chronic kidney disease on hemodialysis. The tuberculin test was performed with the standardized antigen, distributed by the Brazilian Ministry of Health, and the reading occurred after 72 to 96 hours of the application. An association test (Chi-square, Fisher’s exact), prevalence ratio, and multivariate regression tests were performed. Results: the prevalence of latent tuberculosis diagnosed through Tuberculosis Skin Test was 8.5% (15/176). The “has/has had diabetes” (aOR: 0.117; 95%CI: 0.015-0.92) and “having regular garbage collection (aOR: 0.076; 95%CI: 0.008-0.702) factors were associated with a lower probability of having a Positive skin test. Conclusion: the low prevalence of latent tuberculosis identified and the factors associated with it reinforce the need for screening for latent tuberculosis infection for diabetics combined with an analysis of previous risk factors and comorbidities.
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Revista Latino-Americana de Enfermagem
- Vol. 29, e3442
Open AccessPrevalence of latent tuberculosis and associated factors in patients with chronic kidney disease on hemodialysis
Objective: to identify the prevalence of latent tuberculosis in patients with chronic kidney disease on hemodialysis and associated factors. Method: a cross-sectional study conducted with 176 patients with chronic kidney disease on hemodialysis. The tuberculin test was performed with the standardized antigen, distributed by the Brazilian Ministry of Health, and the reading occurred after 72 to 96 hours of the application. An association test (Chi-square, Fisher’s exact), prevalence ratio, and multivariate regression tests were performed. Results: the prevalence of latent tuberculosis diagnosed through Tuberculosis Skin Test was 8.5% (15/176). The “has/has had diabetes” (aOR: 0.117; 95%CI: 0.015-0.92) and “having regular garbage collection (aOR: 0.076; 95%CI: 0.008-0.702) factors were associated with a lower probability of having a Positive skin test. Conclusion: the low prevalence of latent tuberculosis identified and the factors associated with it reinforce the need for screening for latent tuberculosis infection for diabetics combined with an analysis of previous risk factors and comorbidities.